Global Biopharmaceutical Contract Manufacturings Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
- Report Code : MAI1885019
- Published On: Jul, 2020
- Category : Computing & Technology
- Pages : 128
-
The Contract Manufacturing Organization (CMO) is a company that offers a wide range of services, from drug development to pharmaceutical manufacturing, from contracts to pharmaceutical companies. Biopharmaceutical contract manufacturing involves the development and manufacture of biopharmaceutical molecules for biopharmaceutical companies. Biopharmaceuticals include pharmaceutical products such as proteins, nucleic acids, blood components, and vaccines developed from biological sources.
The Biopharmaceutical Contract Manufacturings market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.
Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.
In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the Biopharmaceutical Contract Manufacturings industry.
Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy.
The Biopharmaceutical Contract Manufacturings market can be split based on product types, major applications, and important countries as follows:
Key players in the global Biopharmaceutical Contract Manufacturings market covered in Chapter 12:
Catalent Inc.
Abbvie Inc.
Famar
Recipharm AB
Pfizer Centresource
Aenova
Boehringer Ingelheim
Cambrex Corporation
Baxter Biopharma Solutions
Lonza
Patheon Inc.
Jubilant Life Sciences Ltd.
In Chapter 4 and 14.1, on the basis of types, the Biopharmaceutical Contract Manufacturings market from 2015 to 2025 is primarily split into:
Active Pharmaceutical Ingredient (API) Manufacturing
Finished Dosage Formulation (FDF) Development & Manufacturing
Others
In Chapter 5 and 14.2, on the basis of applications, the Biopharmaceutical Contract Manufacturings market from 2015 to 2025 covers:
Oncology
Central Nervous System
Cardiovascular Disorders
Infectious Diseases
Pulmonary Disorders
Metabolic Disorders
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:
North America (Covered in Chapter 7 and 14)
United States
Canada
Mexico
Europe (Covered in Chapter 8 and 14)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 9 and 14)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 10 and 14)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 11 and 14)
Brazil
Argentina
Columbia
Chile
Others
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
-
With tables and figures helping analyze worldwide Global Biopharmaceutical Contract Manufacturings market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Table of Content
1 Biopharmaceutical Contract Manufacturings Introduction and Market Overview1.1 Objectives of the Study
1.2 Overview of Biopharmaceutical Contract Manufacturings
1.3 Scope of The Study
1.3.1 Key Market Segments
1.3.2 Players Covered
1.3.3 COVID-19's impact on the Biopharmaceutical Contract Manufacturings industry1.4 Methodology of The Study
1.5 Research Data Source
2 Executive Summary2.1 Market Overview
2.1.1 Global Biopharmaceutical Contract Manufacturings Market Size, 2015 – 2020
2.1.2 Global Biopharmaceutical Contract Manufacturings Market Size by Type, 2015 – 2020
2.1.3 Global Biopharmaceutical Contract Manufacturings Market Size by Application, 2015 – 2020
2.1.4 Global Biopharmaceutical Contract Manufacturings Market Size by Region, 2015 - 20252.2 Business Environment Analysis
2.2.1 Global COVID-19 Status and Economic Overview
2.2.2 Influence of COVID-19 Outbreak on Biopharmaceutical Contract Manufacturings Industry Development
3 Industry Chain Analysis3.1 Upstream Raw Material Suppliers of Biopharmaceutical Contract Manufacturings Analysis
3.2 Major Players of Biopharmaceutical Contract Manufacturings
3.3 Biopharmaceutical Contract Manufacturings Manufacturing Cost Structure Analysis
3.3.1 Production Process Analysis
3.3.2 Manufacturing Cost Structure of Biopharmaceutical Contract Manufacturings
3.3.3 Labor Cost of Biopharmaceutical Contract Manufacturings3.4 Market Distributors of Biopharmaceutical Contract Manufacturings
3.5 Major Downstream Buyers of Biopharmaceutical Contract Manufacturings Analysis
3.6 The Impact of Covid-19 From the Perspective of Industry Chain
3.7 Regional Import and Export Controls Will Exist for a Long Time
3.8 Continued downward PMI Spreads Globally
4 Global Biopharmaceutical Contract Manufacturings Market, by Type4.1 Global Biopharmaceutical Contract Manufacturings Value and Market Share by Type (2015-2020)
4.2 Global Biopharmaceutical Contract Manufacturings Production and Market Share by Type (2015-2020)
4.3 Global Biopharmaceutical Contract Manufacturings Value and Growth Rate by Type (2015-2020)
4.3.1 Global Biopharmaceutical Contract Manufacturings Value and Growth Rate of Active Pharmaceutical Ingredient (API) Manufacturing
4.3.2 Global Biopharmaceutical Contract Manufacturings Value and Growth Rate of Finished Dosage Formulation (FDF) Development & Manufacturing
4.3.3 Global Biopharmaceutical Contract Manufacturings Value and Growth Rate of Others4.4 Global Biopharmaceutical Contract Manufacturings Price Analysis by Type (2015-2020)
5 Biopharmaceutical Contract Manufacturings Market, by Application5.1 Downstream Market Overview
5.2 Global Biopharmaceutical Contract Manufacturings Consumption and Market Share by Application (2015-2020)
5.3 Global Biopharmaceutical Contract Manufacturings Consumption and Growth Rate by Application (2015-2020)
5.3.1 Global Biopharmaceutical Contract Manufacturings Consumption and Growth Rate of Oncology (2015-2020)
5.3.2 Global Biopharmaceutical Contract Manufacturings Consumption and Growth Rate of Central Nervous System (2015-2020)
5.3.3 Global Biopharmaceutical Contract Manufacturings Consumption and Growth Rate of Cardiovascular Disorders (2015-2020)
5.3.4 Global Biopharmaceutical Contract Manufacturings Consumption and Growth Rate of Infectious Diseases (2015-2020)
5.3.5 Global Biopharmaceutical Contract Manufacturings Consumption and Growth Rate of Pulmonary Disorders (2015-2020)
5.3.6 Global Biopharmaceutical Contract Manufacturings Consumption and Growth Rate of Metabolic Disorders (2015-2020)
5.3.7 Global Biopharmaceutical Contract Manufacturings Consumption and Growth Rate of Others (2015-2020)
6 Global Biopharmaceutical Contract Manufacturings Market Analysis by Regions6.1 Global Biopharmaceutical Contract Manufacturings Sales, Revenue and Market Share by Regions
6.1.1 Global Biopharmaceutical Contract Manufacturings Sales by Regions (2015-2020)
6.1.2 Global Biopharmaceutical Contract Manufacturings Revenue by Regions (2015-2020)6.2 North America Biopharmaceutical Contract Manufacturings Sales and Growth Rate (2015-2020)
6.3 Europe Biopharmaceutical Contract Manufacturings Sales and Growth Rate (2015-2020)
6.4 Asia-Pacific Biopharmaceutical Contract Manufacturings Sales and Growth Rate (2015-2020)
6.5 Middle East and Africa Biopharmaceutical Contract Manufacturings Sales and Growth Rate (2015-2020)
6.6 South America Biopharmaceutical Contract Manufacturings Sales and Growth Rate (2015-2020)
7 North America Biopharmaceutical Contract Manufacturings Market Analysis by Countries7.1 The Influence of COVID-19 on North America Market
7.2 North America Biopharmaceutical Contract Manufacturings Sales, Revenue and Market Share by Countries
7.2.1 North America Biopharmaceutical Contract Manufacturings Sales by Countries (2015-2020)
7.2.2 North America Biopharmaceutical Contract Manufacturings Revenue by Countries (2015-2020)7.3 United States Biopharmaceutical Contract Manufacturings Sales and Growth Rate (2015-2020)
7.4 Canada Biopharmaceutical Contract Manufacturings Sales and Growth Rate (2015-2020)
7.5 Mexico Biopharmaceutical Contract Manufacturings Sales and Growth Rate (2015-2020)
8 Europe Biopharmaceutical Contract Manufacturings Market Analysis by Countries8.1 The Influence of COVID-19 on Europe Market
8.2 Europe Biopharmaceutical Contract Manufacturings Sales, Revenue and Market Share by Countries
8.2.1 Europe Biopharmaceutical Contract Manufacturings Sales by Countries (2015-2020)
8.2.2 Europe Biopharmaceutical Contract Manufacturings Revenue by Countries (2015-2020)8.3 Germany Biopharmaceutical Contract Manufacturings Sales and Growth Rate (2015-2020)
8.4 UK Biopharmaceutical Contract Manufacturings Sales and Growth Rate (2015-2020)
8.5 France Biopharmaceutical Contract Manufacturings Sales and Growth Rate (2015-2020)
8.6 Italy Biopharmaceutical Contract Manufacturings Sales and Growth Rate (2015-2020)
8.7 Spain Biopharmaceutical Contract Manufacturings Sales and Growth Rate (2015-2020)
8.8 Russia Biopharmaceutical Contract Manufacturings Sales and Growth Rate (2015-2020)
9 Asia Pacific Biopharmaceutical Contract Manufacturings Market Analysis by Countries9.1 The Influence of COVID-19 on Asia Pacific Market
9.2 Asia Pacific Biopharmaceutical Contract Manufacturings Sales, Revenue and Market Share by Countries
9.2.1 Asia Pacific Biopharmaceutical Contract Manufacturings Sales by Countries (2015-2020)
9.2.2 Asia Pacific Biopharmaceutical Contract Manufacturings Revenue by Countries (2015-2020)9.3 China Biopharmaceutical Contract Manufacturings Sales and Growth Rate (2015-2020)
9.4 Japan Biopharmaceutical Contract Manufacturings Sales and Growth Rate (2015-2020)
9.5 South Korea Biopharmaceutical Contract Manufacturings Sales and Growth Rate (2015-2020)
9.6 India Biopharmaceutical Contract Manufacturings Sales and Growth Rate (2015-2020)
9.7 Southeast Asia Biopharmaceutical Contract Manufacturings Sales and Growth Rate (2015-2020)
9.8 Australia Biopharmaceutical Contract Manufacturings Sales and Growth Rate (2015-2020)
10 Middle East and Africa Biopharmaceutical Contract Manufacturings Market Analysis by Countries10.1 The Influence of COVID-19 on Middle East and Africa Market
10.2 Middle East and Africa Biopharmaceutical Contract Manufacturings Sales, Revenue and Market Share by Countries
10.2.1 Middle East and Africa Biopharmaceutical Contract Manufacturings Sales by Countries (2015-2020)
10.2.2 Middle East and Africa Biopharmaceutical Contract Manufacturings Revenue by Countries (2015-2020)10.3 Saudi Arabia Biopharmaceutical Contract Manufacturings Sales and Growth Rate (2015-2020)
10.4 UAE Biopharmaceutical Contract Manufacturings Sales and Growth Rate (2015-2020)
10.5 Egypt Biopharmaceutical Contract Manufacturings Sales and Growth Rate (2015-2020)
10.6 Nigeria Biopharmaceutical Contract Manufacturings Sales and Growth Rate (2015-2020)
10.7 South Africa Biopharmaceutical Contract Manufacturings Sales and Growth Rate (2015-2020)
11 South America Biopharmaceutical Contract Manufacturings Market Analysis by Countries11.1 The Influence of COVID-19 on Middle East and Africa Market
11.2 South America Biopharmaceutical Contract Manufacturings Sales, Revenue and Market Share by Countries
11.2.1 South America Biopharmaceutical Contract Manufacturings Sales by Countries (2015-2020)
11.2.2 South America Biopharmaceutical Contract Manufacturings Revenue by Countries (2015-2020)11.3 Brazil Biopharmaceutical Contract Manufacturings Sales and Growth Rate (2015-2020)
11.4 Argentina Biopharmaceutical Contract Manufacturings Sales and Growth Rate (2015-2020)
11.5 Columbia Biopharmaceutical Contract Manufacturings Sales and Growth Rate (2015-2020)
11.6 Chile Biopharmaceutical Contract Manufacturings Sales and Growth Rate (2015-2020)
12 Competitive Landscape12.1 Catalent Inc.
12.1.1 Catalent Inc. Basic Information
12.1.2 Biopharmaceutical Contract Manufacturings Product Introduction
12.1.3 Catalent Inc. Production, Value, Price, Gross Margin 2015-202012.2 Abbvie Inc.
12.2.1 Abbvie Inc. Basic Information
12.2.2 Biopharmaceutical Contract Manufacturings Product Introduction
12.2.3 Abbvie Inc. Production, Value, Price, Gross Margin 2015-202012.3 Famar
12.3.1 Famar Basic Information
12.3.2 Biopharmaceutical Contract Manufacturings Product Introduction
12.3.3 Famar Production, Value, Price, Gross Margin 2015-202012.4 Recipharm AB
12.4.1 Recipharm AB Basic Information
12.4.2 Biopharmaceutical Contract Manufacturings Product Introduction
12.4.3 Recipharm AB Production, Value, Price, Gross Margin 2015-202012.5 Pfizer Centresource
12.5.1 Pfizer Centresource Basic Information
12.5.2 Biopharmaceutical Contract Manufacturings Product Introduction
12.5.3 Pfizer Centresource Production, Value, Price, Gross Margin 2015-202012.6 Aenova
12.6.1 Aenova Basic Information
12.6.2 Biopharmaceutical Contract Manufacturings Product Introduction
12.6.3 Aenova Production, Value, Price, Gross Margin 2015-2020
12.7 Boehringer Ingelheim
12.7.1 Boehringer Ingelheim Basic Information
12.7.2 Biopharmaceutical Contract Manufacturings Product Introduction
12.7.3 Boehringer Ingelheim Production, Value, Price, Gross Margin 2015-2020
12.8 Cambrex Corporation
12.8.1 Cambrex Corporation Basic Information
12.8.2 Biopharmaceutical Contract Manufacturings Product Introduction
12.8.3 Cambrex Corporation Production, Value, Price, Gross Margin 2015-2020
12.9 Baxter Biopharma Solutions
12.9.1 Baxter Biopharma Solutions Basic Information
12.9.2 Biopharmaceutical Contract Manufacturings Product Introduction
12.9.3 Baxter Biopharma Solutions Production, Value, Price, Gross Margin 2015-202012.10 Lonza
12.10.1 Lonza Basic Information
12.10.2 Biopharmaceutical Contract Manufacturings Product Introduction
12.10.3 Lonza Production, Value, Price, Gross Margin 2015-2020
12.11 Patheon Inc.
12.11.1 Patheon Inc. Basic Information
12.11.2 Biopharmaceutical Contract Manufacturings Product Introduction
12.11.3 Patheon Inc. Production, Value, Price, Gross Margin 2015-2020
12.12 Jubilant Life Sciences Ltd.
12.12.1 Jubilant Life Sciences Ltd. Basic Information
12.12.2 Biopharmaceutical Contract Manufacturings Product Introduction
12.12.3 Jubilant Life Sciences Ltd. Production, Value, Price, Gross Margin 2015-2020
13 Industry Outlook13.1 Market Driver Analysis
13.1.2 Market Restraints Analysis
13.1.3 Market Trends Analysis13.2 Merger, Acquisition and New Investment
13.3 News of Product Release
14 Global Biopharmaceutical Contract Manufacturings Market Forecast14.1 Global Biopharmaceutical Contract Manufacturings Market Value & Volume Forecast, by Type (2020-2025)
14.1.1 Active Pharmaceutical Ingredient (API) Manufacturing Market Value and Volume Forecast (2020-2025)
14.1.2 Finished Dosage Formulation (FDF) Development & Manufacturing Market Value and Volume Forecast (2020-2025)
14.1.3 Others Market Value and Volume Forecast (2020-2025)14.2 Global Biopharmaceutical Contract Manufacturings Market Value & Volume Forecast, by Application (2020-2025)
14.2.1 Oncology Market Value and Volume Forecast (2020-2025)
14.2.2 Central Nervous System Market Value and Volume Forecast (2020-2025)
14.2.3 Cardiovascular Disorders Market Value and Volume Forecast (2020-2025)
14.2.4 Infectious Diseases Market Value and Volume Forecast (2020-2025)
14.2.5 Pulmonary Disorders Market Value and Volume Forecast (2020-2025)
14.2.6 Metabolic Disorders Market Value and Volume Forecast (2020-2025)
14.2.7 Others Market Value and Volume Forecast (2020-2025)14.3 Biopharmaceutical Contract Manufacturings Market Analysis and Forecast by Region
14.3.1 North America Market Value and Consumption Forecast (2020-2025)
14.3.2 Europe Market Value and Consumption Forecast (2020-2025)
14.3.3 Asia Pacific Market Value and Consumption Forecast (2020-2025)
14.3.4 Middle East and Africa Market Value and Consumption Forecast (2020-2025)
14.3.5 South America Market Value and Consumption Forecast (2020-2025)
15 New Project Feasibility Analysis15.1 Industry Barriers and New Entrants SWOT Analysis
15.1.1 Porter’s Five Forces Analysis
15.1.2 New Entrants SWOT Analysis15.2 Analysis and Suggestions on New Project Investment
List of Tables and Figures
Figure Product Picture of Biopharmaceutical Contract Manufacturings
Table Product Specification of Biopharmaceutical Contract Manufacturings
Table Biopharmaceutical Contract Manufacturings Key Market Segments
Table Key Players Biopharmaceutical Contract Manufacturings Covered
Figure Global Biopharmaceutical Contract Manufacturings Market Size, 2015 – 2025
Table Different Types of Biopharmaceutical Contract Manufacturings
Figure Global Biopharmaceutical Contract Manufacturings Value ($) Segment by Type from 2015-2020
Figure Global Biopharmaceutical Contract Manufacturings Market Share by Types in 2019
Table Different Applications of Biopharmaceutical Contract Manufacturings
Figure Global Biopharmaceutical Contract Manufacturings Value ($) Segment by Applications from 2015-2020
Figure Global Biopharmaceutical Contract Manufacturings Market Share by Applications in 2019
Figure Global Biopharmaceutical Contract Manufacturings Market Share by Regions in 2019
Figure North America Biopharmaceutical Contract Manufacturings Production Value ($) and Growth Rate (2015-2020)
Figure Europe Biopharmaceutical Contract Manufacturings Production Value ($) and Growth Rate (2015-2020)
Figure Asia Pacific Biopharmaceutical Contract Manufacturings Production Value ($) and Growth Rate (2015-2020)
Figure Middle East and Africa Biopharmaceutical Contract Manufacturings Production Value ($) and Growth Rate (2015-2020)
Figure South America Biopharmaceutical Contract Manufacturings Production Value ($) and Growth Rate (2015-2020)
Table Global COVID-19 Status and Economic Overview
Figure Global COVID-19 Status
Figure COVID-19 Comparison of Major Countries
Figure Industry Chain Analysis of Biopharmaceutical Contract Manufacturings
Table Upstream Raw Material Suppliers of Biopharmaceutical Contract Manufacturings with Contact Information
Table Major Players Headquarters, and Service Area of Biopharmaceutical Contract Manufacturings
Figure Major Players Production Value Market Share of Biopharmaceutical Contract Manufacturings in 2019
Table Major Players Biopharmaceutical Contract Manufacturings Product Types in 2019
Figure Production Process of Biopharmaceutical Contract Manufacturings
Figure Manufacturing Cost Structure of Biopharmaceutical Contract Manufacturings
Figure Channel Status of Biopharmaceutical Contract Manufacturings
Table Major Distributors of Biopharmaceutical Contract Manufacturings with Contact Information
Table Major Downstream Buyers of Biopharmaceutical Contract Manufacturings with Contact Information
Table Global Biopharmaceutical Contract Manufacturings Value ($) by Type (2015-2020)
Table Global Biopharmaceutical Contract Manufacturings Value Share by Type (2015-2020)
Figure Global Biopharmaceutical Contract Manufacturings Value Share by Type (2015-2020)
Table Global Biopharmaceutical Contract Manufacturings Production by Type (2015-2020)
Table Global Biopharmaceutical Contract Manufacturings Production Share by Type (2015-2020)
Figure Global Biopharmaceutical Contract Manufacturings Production Share by Type (2015-2020)
Figure Global Biopharmaceutical Contract Manufacturings Value ($) and Growth Rate of Active Pharmaceutical Ingredient (API) Manufacturing (2015-2020)
Figure Global Biopharmaceutical Contract Manufacturings Value ($) and Growth Rate of Finished Dosage Formulation (FDF) Development & Manufacturing (2015-2020)
Figure Global Biopharmaceutical Contract Manufacturings Value ($) and Growth Rate of Others (2015-2020)
Figure Global Biopharmaceutical Contract Manufacturings Price by Type (2015-2020)
Figure Downstream Market Overview
Table Global Biopharmaceutical Contract Manufacturings Consumption by Application (2015-2020)
Table Global Biopharmaceutical Contract Manufacturings Consumption Market Share by Application (2015-2020)
Figure Global Biopharmaceutical Contract Manufacturings Consumption Market Share by Application (2015-2020)
Figure Global Biopharmaceutical Contract Manufacturings Consumption and Growth Rate of Oncology (2015-2020)
Figure Global Biopharmaceutical Contract Manufacturings Consumption and Growth Rate of Central Nervous System (2015-2020)
Figure Global Biopharmaceutical Contract Manufacturings Consumption and Growth Rate of Cardiovascular Disorders (2015-2020)
Figure Global Biopharmaceutical Contract Manufacturings Consumption and Growth Rate of Infectious Diseases (2015-2020)
Figure Global Biopharmaceutical Contract Manufacturings Consumption and Growth Rate of Pulmonary Disorders (2015-2020)
Figure Global Biopharmaceutical Contract Manufacturings Consumption and Growth Rate of Metabolic Disorders (2015-2020)
Figure Global Biopharmaceutical Contract Manufacturings Consumption and Growth Rate of Others (2015-2020)
Figure Global Biopharmaceutical Contract Manufacturings Sales and Growth Rate (2015-2020)
Figure Global Biopharmaceutical Contract Manufacturings Revenue (M USD) and Growth (2015-2020)
Table Global Biopharmaceutical Contract Manufacturings Sales by Regions (2015-2020)
Table Global Biopharmaceutical Contract Manufacturings Sales Market Share by Regions (2015-2020)
Table Global Biopharmaceutical Contract Manufacturings Revenue (M USD) by Regions (2015-2020)
Table Global Biopharmaceutical Contract Manufacturings Revenue Market Share by Regions (2015-2020)
Table Global Biopharmaceutical Contract Manufacturings Revenue Market Share by Regions in 2015
Table Global Biopharmaceutical Contract Manufacturings Revenue Market Share by Regions in 2019
Figure North America Biopharmaceutical Contract Manufacturings Sales and Growth Rate (2015-2020)
Figure Europe Biopharmaceutical Contract Manufacturings Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Biopharmaceutical Contract Manufacturings Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Biopharmaceutical Contract Manufacturings Sales and Growth Rate (2015-2020)
Figure South America Biopharmaceutical Contract Manufacturings Sales and Growth Rate (2015-2020)
Figure North America COVID-19 Status
Figure North America COVID-19 Confirmed Cases Major Distribution
Figure North America Biopharmaceutical Contract Manufacturings Revenue (M USD) and Growth (2015-2020)
Table North America Biopharmaceutical Contract Manufacturings Sales by Countries (2015-2020)
Table North America Biopharmaceutical Contract Manufacturings Sales Market Share by Countries (2015-2020)
Table North America Biopharmaceutical Contract Manufacturings Revenue (M USD) by Countries (2015-2020)
Table North America Biopharmaceutical Contract Manufacturings Revenue Market Share by Countries (2015-2020)
Figure United States Biopharmaceutical Contract Manufacturings Sales and Growth Rate (2015-2020)
Figure Canada Biopharmaceutical Contract Manufacturings Sales and Growth Rate (2015-2020)
Figure Mexico Biopharmaceutical Contract Manufacturings Sales and Growth (2015-2020)
Figure Europe COVID-19 Status
Figure Europe COVID-19 Confirmed Cases Major Distribution
Figure Europe Biopharmaceutical Contract Manufacturings Revenue (M USD) and Growth (2015-2020)
Table Europe Biopharmaceutical Contract Manufacturings Sales by Countries (2015-2020)
Table Europe Biopharmaceutical Contract Manufacturings Sales Market Share by Countries (2015-2020)
Table Europe Biopharmaceutical Contract Manufacturings Revenue (M USD) by Countries (2015-2020)
Table Europe Biopharmaceutical Contract Manufacturings Revenue Market Share by Countries (2015-2020)
Figure Germany Biopharmaceutical Contract Manufacturings Sales and Growth Rate (2015-2020)
Figure UK Biopharmaceutical Contract Manufacturings Sales and Growth Rate (2015-2020)
Figure France Biopharmaceutical Contract Manufacturings Sales and Growth (2015-2020)
Figure Italy Biopharmaceutical Contract Manufacturings Sales and Growth (2015-2020)
Figure Spain Biopharmaceutical Contract Manufacturings Sales and Growth (2015-2020)
Figure Russia Biopharmaceutical Contract Manufacturings Sales and Growth (2015-2020)
Figure Asia Pacific COVID-19 Status
Figure Asia Pacific Biopharmaceutical Contract Manufacturings Revenue (M USD) and Growth (2015-2020)
Table Asia Pacific Biopharmaceutical Contract Manufacturings Sales by Countries (2015-2020)
Table Asia Pacific Biopharmaceutical Contract Manufacturings Sales Market Share by Countries (2015-2020)
Table Asia Pacific Biopharmaceutical Contract Manufacturings Revenue (M USD) by Countries (2015-2020)
Table Asia Pacific Biopharmaceutical Contract Manufacturings Revenue Market Share by Countries (2015-2020)
Figure China Biopharmaceutical Contract Manufacturings Sales and Growth Rate (2015-2020)
Figure Japan Biopharmaceutical Contract Manufacturings Sales and Growth Rate (2015-2020)
Figure South Korea Biopharmaceutical Contract Manufacturings Sales and Growth (2015-2020)
Figure India Biopharmaceutical Contract Manufacturings Sales and Growth (2015-2020)
Figure Southeast Asia Biopharmaceutical Contract Manufacturings Sales and Growth (2015-2020)
Figure Australia Biopharmaceutical Contract Manufacturings Sales and Growth (2015-2020)
Figure Middle East Biopharmaceutical Contract Manufacturings Revenue (M USD) and Growth (2015-2020)
Table Middle East Biopharmaceutical Contract Manufacturings Sales by Countries (2015-2020)
Table Middle East and Africa Biopharmaceutical Contract Manufacturings Sales Market Share by Countries (2015-2020)
Table Middle East and Africa Biopharmaceutical Contract Manufacturings Revenue (M USD) by Countries (2015-2020)
Table Middle East and Africa Biopharmaceutical Contract Manufacturings Revenue Market Share by Countries (2015-2020)
Figure Saudi Arabia Biopharmaceutical Contract Manufacturings Sales and Growth Rate (2015-2020)
Figure UAE Biopharmaceutical Contract Manufacturings Sales and Growth Rate (2015-2020)
Figure Egypt Biopharmaceutical Contract Manufacturings Sales and Growth (2015-2020)
Figure Nigeria Biopharmaceutical Contract Manufacturings Sales and Growth (2015-2020)
Figure South Africa Biopharmaceutical Contract Manufacturings Sales and Growth (2015-2020)
Figure South America Biopharmaceutical Contract Manufacturings Revenue (M USD) and Growth (2015-2020)
Table South America Biopharmaceutical Contract Manufacturings Sales by Countries (2015-2020)
Table South America Biopharmaceutical Contract Manufacturings Sales Market Share by Countries (2015-2020)
Table South America Biopharmaceutical Contract Manufacturings Revenue (M USD) by Countries (2015-2020)
Table South America Biopharmaceutical Contract Manufacturings Revenue Market Share by Countries (2015-2020)
Figure Brazil Biopharmaceutical Contract Manufacturings Sales and Growth Rate (2015-2020)
Figure Argentina Biopharmaceutical Contract Manufacturings Sales and Growth Rate (2015-2020)
Figure Columbia Biopharmaceutical Contract Manufacturings Sales and Growth (2015-2020)
Figure Chile Biopharmaceutical Contract Manufacturings Sales and Growth (2015-2020)
Figure Top 3 Market Share of Biopharmaceutical Contract Manufacturings Companies in 2019
Figure Top 6 Market Share of Biopharmaceutical Contract Manufacturings Companies in 2019
Table Major Players Production Value ($) Share (2015-2020)
Table Catalent Inc. Profile
Table Catalent Inc. Product Introduction
Figure Catalent Inc. Production and Growth Rate
Figure Catalent Inc. Value ($) Market Share 2015-2020
Table Abbvie Inc. Profile
Table Abbvie Inc. Product Introduction
Figure Abbvie Inc. Production and Growth Rate
Figure Abbvie Inc. Value ($) Market Share 2015-2020
Table Famar Profile
Table Famar Product Introduction
Figure Famar Production and Growth Rate
Figure Famar Value ($) Market Share 2015-2020
Table Recipharm AB Profile
Table Recipharm AB Product Introduction
Figure Recipharm AB Production and Growth Rate
Figure Recipharm AB Value ($) Market Share 2015-2020
Table Pfizer Centresource Profile
Table Pfizer Centresource Product Introduction
Figure Pfizer Centresource Production and Growth Rate
Figure Pfizer Centresource Value ($) Market Share 2015-2020
Table Aenova Profile
Table Aenova Product Introduction
Figure Aenova Production and Growth Rate
Figure Aenova Value ($) Market Share 2015-2020
Table Boehringer Ingelheim Profile
Table Boehringer Ingelheim Product Introduction
Figure Boehringer Ingelheim Production and Growth Rate
Figure Boehringer Ingelheim Value ($) Market Share 2015-2020
Table Cambrex Corporation Profile
Table Cambrex Corporation Product Introduction
Figure Cambrex Corporation Production and Growth Rate
Figure Cambrex Corporation Value ($) Market Share 2015-2020
Table Baxter Biopharma Solutions Profile
Table Baxter Biopharma Solutions Product Introduction
Figure Baxter Biopharma Solutions Production and Growth Rate
Figure Baxter Biopharma Solutions Value ($) Market Share 2015-2020
Table Lonza Profile
Table Lonza Product Introduction
Figure Lonza Production and Growth Rate
Figure Lonza Value ($) Market Share 2015-2020
Table Patheon Inc. Profile
Table Patheon Inc. Product Introduction
Figure Patheon Inc. Production and Growth Rate
Figure Patheon Inc. Value ($) Market Share 2015-2020
Table Jubilant Life Sciences Ltd. Profile
Table Jubilant Life Sciences Ltd. Product Introduction
Figure Jubilant Life Sciences Ltd. Production and Growth Rate
Figure Jubilant Life Sciences Ltd. Value ($) Market Share 2015-2020
Table Market Driving Factors of Biopharmaceutical Contract Manufacturings
Table Merger, Acquisition and New Investment
Table Global Biopharmaceutical Contract Manufacturings Market Value ($) Forecast, by Type
Table Global Biopharmaceutical Contract Manufacturings Market Volume Forecast, by Type
Figure Global Biopharmaceutical Contract Manufacturings Market Value ($) and Growth Rate Forecast of Active Pharmaceutical Ingredient (API) Manufacturing (2020-2025)
Figure Global Biopharmaceutical Contract Manufacturings Market Volume ($) and Growth Rate Forecast of Active Pharmaceutical Ingredient (API) Manufacturing (2020-2025)
Figure Global Biopharmaceutical Contract Manufacturings Market Value ($) and Growth Rate Forecast of Finished Dosage Formulation (FDF) Development & Manufacturing (2020-2025)
Figure Global Biopharmaceutical Contract Manufacturings Market Volume ($) and Growth Rate Forecast of Finished Dosage Formulation (FDF) Development & Manufacturing (2020-2025)
Figure Global Biopharmaceutical Contract Manufacturings Market Value ($) and Growth Rate Forecast of Others (2020-2025)
Figure Global Biopharmaceutical Contract Manufacturings Market Volume ($) and Growth Rate Forecast of Others (2020-2025)
Table Global Market Value ($) Forecast by Application (2020-2025)
Table Global Market Volume Forecast by Application (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Oncology (2020-2025)
Figure Market Volume and Growth Rate Forecast of Oncology (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Central Nervous System (2020-2025)
Figure Market Volume and Growth Rate Forecast of Central Nervous System (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Cardiovascular Disorders (2020-2025)
Figure Market Volume and Growth Rate Forecast of Cardiovascular Disorders (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Infectious Diseases (2020-2025)
Figure Market Volume and Growth Rate Forecast of Infectious Diseases (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Pulmonary Disorders (2020-2025)
Figure Market Volume and Growth Rate Forecast of Pulmonary Disorders (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Metabolic Disorders (2020-2025)
Figure Market Volume and Growth Rate Forecast of Metabolic Disorders (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Others (2020-2025)
Figure Market Volume and Growth Rate Forecast of Others (2020-2025)
Figure North America Market Value ($) and Growth Rate Forecast (2020-2025)
Figure North America Consumption and Growth Rate Forecast (2020-2025)
Figure Europe Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Europe Consumption and Growth Rate Forecast (2020-2025)
Figure Asia Pacific Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Asia Pacific Consumption and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Consumption and Growth Rate Forecast (2020-2025)
Figure South America Market Value ($) and Growth Rate Forecast (2020-2025)
Figure South America Consumption and Growth Rate Forecast (2020-2025)
Figure Porter’s Five Forces Analysis
Table New Entrants SWOT Analysis
Table New Project Analysis of Investment Recovery
-
The Global Biopharmaceutical Contract Manufacturings Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
In 2023, the Global Biopharmaceutical Contract Manufacturings Market share surpassed USD xx million, and between 2024 and 2029, it will grow at a CAGR of yy%.
The influx of capital into the Global Biopharmaceutical Contract Manufacturings Market, as well as the deployment of technologies designed to increase efficiency and yield high volume, are paving the way for promising market opportunities.
In this highly competitive and rapidly evolving Global Biopharmaceutical Contract Manufacturings Industry, top strategic priorities such as innovation, diversification, and M&A would remain consistent.
